P

Inventor

ETSCHENBERG EUGEN

DE19 patents
⚠️ This page may combine multiple inventors who share the name “ETSCHENBERG EUGEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NATTERMANN A & CIE

12 patents
US4309421AJan 5, 1982

Stabilized parenterally administrable solutions

NATTERMANN A & CIE74 citations95
US4711961ADec 8, 1987

Benzisoselenazolethiones and process for the treatment of various diseases in humans

NATTERMANN A & CIE27 citations92
US4576626AMar 18, 1986

Foliage fertilizers

NATTERMANN A & CIE26 citations89
US4550168AOct 29, 1985

Benzisoselenazolones and a process for the treatment of inflammatory diseases

NATTERMANN A & CIE23 citations81
US4309420AJan 5, 1982

Stable injectable solutions of indoleacetic acid derivatives

NATTERMANN A & CIE26 citations81
US4352799AOct 5, 1982

2-Phenyl-1,2-benzisoselenazol-3(2H)-one containing pharmaceutical preparations and process for the treatment of rheumatic diseases

NATTERMANN A & CIE27 citations77
US4454068AJun 12, 1984

Cycloalkyl derivatives of benzisoselenazolones

NATTERMANN A & CIE8 citations73
US4397858AAug 9, 1983

Treatment of rheumatism and arteriosclerosis with n-halogenophenyl-benzisothiazoles

NATTERMANN A & CIE9 citations73
US4774252ASep 27, 1988

Benzisoselenazolonyl derivatives and processes for the treatment of rheumatic disease

NATTERMANN A & CIE19 citations69
US4873350AOct 10, 1989

Diselenobis-benzoic acid amides of primary and secondary amines and processes for the treatment of diseases in humans caused by a cell injury

NATTERMANN A & CIE10 citations68
US4329361AMay 11, 1982

Use of rosmarinic acid in the treatment of inflammations and pharmaceutical products used therein

NATTERMANN A & CIE9 citations68
US4505854AMar 19, 1985

Optically active dipeptides and the use thereof as tissue dissolving and histolytic agent in human beings

NATTERMANN A & CIE0 citations46

TROPONWERKE GMBH & CO KG

5 patents

BAYER AG

2 patents